Pleiotropic Effects of the Protease-Activated Receptor 1 (PAR1) Inhibitor, Vorapaxar, on Atherosclerosis and Vascular InflammationJulian Friebel, Ursula Rauch, Marco Witkowski et al.|Cells|2021Cited by 29
Metformin Is Associated with Reduced Tissue Factor Procoagulant Activity in Patients with Poorly Controlled DiabetesMarco Witkowski, Ursula Rauch, Ulf Landmesser et al.|Cardiovascular Drugs and Therapy|2020Cited by 23
Cytotoxic CD8+ T Cells Are Involved in the Thrombo-Inflammatory Response during First-Diagnosed Atrial FibrillationJulian Friebel, Ursula Rauch, Marco Witkowski et al.|Cells|2022Cited by 16
Intestinal Barrier Dysfunction and Microbial Translocation in Patients with First-Diagnosed Atrial FibrillationLeon Blöbaum, Julian Friebel, Marco Witkowski et al.|Biomedicines|2023Cited by 15